Boston Scientific (BSX) Shares Outstanding (Diluted Average) (2009 - 2026)

Boston Scientific's Shares Outstanding (Diluted Average) history runs 18 years deep, the most recent figure standing at $1.5 billion for Q1 2026.

• In Q1 2026, Shares Outstanding (Diluted Average) changed 0.13% year-over-year to $1.5 billion; the TTM figure through Mar 2026 stood at $1.5 billion (changed 0.13% YoY), while the FY2025 annual figure was $1.5 billion, up 0.58% from the prior year.
• Shares Outstanding (Diluted Average) came in at $1.5 billion for Q1 2026 at Boston Scientific, roughly flat from $1.5 billion in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $1.5 billion in Q3 2025 to a low of $1.4 billion in Q2 2022.
• A 5-year average of $1.5 billion and a median of $1.5 billion in 2024 frame the typical range for Shares Outstanding (Diluted Average).
• Across the five-year window, Shares Outstanding (Diluted Average) rose 2.47% in 2024 and climbed 0.13% in 2026, its largest moves.
• Boston Scientific's Shares Outstanding (Diluted Average) stood at $1.4 billion in 2022, then climbed by 1.65% to $1.5 billion in 2023, then grew by 1.53% to $1.5 billion in 2024, then grew by 0.58% to $1.5 billion in 2025, then climbed by 0.03% to $1.5 billion in 2026.
• According to Business Quant data, Shares Outstanding (Diluted Average) over the past three periods registered $1.5 billion, $1.5 billion, and $1.5 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison